Industry Veteran John DelliSanti Appointed CEO
Noel Figueroa Appointed Interim CFO
Positioned to Accelerate Mission to Support Every Transformative Health Innovation
Piscataway, NJ, 4/26/24 – Sampled, the next-generation laboratory that unlocks the valuable data in any biological sample, today announced the appointment of John DelliSanti as CEO, effective immediately. He succeeds Robin Grimwood, who will serve as an advisor to Sampled to help ensure a seamless transition.
“I am thrilled to join Sampled as its next leader, having been drawn to its unique mission and compelling commercial position,” said Mr. DelliSanti. “With labs and partners around the world, Sampled is at an inflection point and I am energized to help it realize its next phase of growth. I look forward to applying my experience, alongside the many talented Sampled employees, to allow health innovators to make breakthroughs faster and easier.”
“It has been a privilege and an honor to be part of this journey, as we’ve transitioned from RUCDR to Infinity BiologiX, to Sampled,” said Mr. Grimwood. “Sampled has realized many achievements, while successfully navigating through the COVID pandemic, and I’ve been honored to work alongside the incredible Sampled team. I am confident John is the right leader to further Sampled’s mission and strategy and look forward to the team’s continued success.”
“This leadership transition positions Sampled to accelerate its strategy of delivering exceptional services to its clients across the healthcare landscape,” said Sarah Hersey, Independent Director. “We thank Robin for his unwavering commitment and are excited to benefit from John’s considerable experience and expertise. The Board and I are confident that with these changes Sampled will remain at the forefront of this industry.”
Additionally, Amit Bhalla, Chief Financial Officer, has decided to leave the company to pursue other opportunities. Sampled is conducting a thorough search to identify its next CFO. Noel Figueroa, Vice President and Corporate Controller, will serve as interim CFO.
Mr. DelliSanti brings extensive experience to this new role. He was most recently Chief Commercial Officer for Taconic Biosciences. John has a proven track record of commercial success in the healthcare industry, having previously held leadership positions at ArisGlobal, Carestream Health, and Caliper Life Sciences. Mr. DelliSanti holds an B.S. and MBA from Fordham University.
About Sampled
Sampled enable clients to advance human health by leveraging active biological samples through; preservation, immortalization and utilization in comprehensive multiomics research in the only Global Integrated Analytical Biorepository. Our vision is a world where we make health innovation easier, with a mission for Sampled to be behind every transformative health innovation. Sampled is headquartered in Piscataway, N.J. with labs across the US and the UK and partner labs in the Netherlands, China and Australia.
Infinity BiologiX LLC, Roylance Stability Storage Limited and Roylance Scientific Limited are doing business as Sampled. For more information, please visit www.sampled.com
